Delivery Order SPE2DB24D2100-SPE2DB24FBCEB

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,672.48, is for the delivery of Valtoco 10 mg nasal sprays. This is a firm fixed-price delivery order that does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valtoco 10 mg nasal sprays. The $7,430.91 delivery order is a Firm Fixed Price contract with a completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a comprehensive range of...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valtoco 10 mg nasal sprays. The contract is a Delivery Order with a Firm Fixed Price of $2,063.39 and a completion date of August 22, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Valtoco 20 mg nasal sprays. The contract has a ceiling value of $1,396.68 and a completion date of May 1, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Valtoco 10 mg nasal sprays. The contract has a firm fixed price of $1,491.47 and a completion date of June 13, 2025. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWEHF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,508.72, is for the delivery of Valtoco 10MG nasal spray. This is a firm fixed-price delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VALTOCO 10 MG NASAL SPRAYS. The firm-fixed-price delivery order, valued at $1,979.40, has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, with an ID of SPE2DB22D1200|SPE2DB24FN3LR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,671.52 firm fixed-price delivery order is for the supply of Valtoco 15 mg nasal sprays. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10 mg VALTOCO nasal sprays. The $1,254.36 firm fixed-price delivery order has a completion date of November 8, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYA1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,394.78 delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type, with an ultimate completion date of October 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCEB
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,912.81 fixed-price delivery order is for the supply of Valtoco 10 mg nasal sprays, with a performance period through June 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 5/17/25, 9:55 AM